Re: Precedence in Gene Therapy Pricing
in response to
by
posted on
Jan 04, 2018 08:55AM
,,,,,,and if the stock price is to trade on a more technical basis than news oriented then we could see $1.75 once agian or even as low as the $1.35 level,,especially if we get more dilution this quarter or next. The continued dilution is a high probability,,,so breaking and holding above the trend line is somewhat important in my mind.......jmo.....we have not really traded on technicals so I would hope news and more analyst coverage will propell us upwards shedding this downtrend once and for all time....again......jmo